A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Clinical trial NCT01941043 · COMPLETED
Trial details
- NCT number
- NCT01941043
- Sponsor
- Avalo Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2014-09-01
- Enrollment
- 1357
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.